...
机译:基于硫代虫毒的铅优化,以发现高效率和低毒性的抗胃癌药剂
Zhengzhou Univ Collaborat Innovat Ctr New Drug Res &
Safety Eval Sch Pharmaceut Sci Key Lab Adv;
Zhengzhou Univ Collaborat Innovat Ctr New Drug Res &
Safety Eval Sch Pharmaceut Sci Key Lab Adv;
Zhengzhou Univ Collaborat Innovat Ctr New Drug Res &
Safety Eval Sch Pharmaceut Sci Key Lab Adv;
Zhengzhou Univ Collaborat Innovat Ctr New Drug Res &
Safety Eval Sch Pharmaceut Sci Key Lab Adv;
Zhengzhou Univ Collaborat Innovat Ctr New Drug Res &
Safety Eval Sch Pharmaceut Sci Key Lab Adv;
Zhengzhou Univ Collaborat Innovat Ctr New Drug Res &
Safety Eval Sch Pharmaceut Sci Key Lab Adv;
Zhengzhou Univ Collaborat Innovat Ctr New Drug Res &
Safety Eval Sch Pharmaceut Sci Key Lab Adv;
Zhengzhou Univ Collaborat Innovat Ctr New Drug Res &
Safety Eval Sch Pharmaceut Sci Key Lab Adv;
Zhengzhou Univ Collaborat Innovat Ctr New Drug Res &
Safety Eval Sch Pharmaceut Sci Key Lab Adv;
Zhengzhou Univ Collaborat Innovat Ctr New Drug Res &
Safety Eval Sch Pharmaceut Sci Key Lab Adv;
Zhengzhou Univ Collaborat Innovat Ctr New Drug Res &
Safety Eval Sch Pharmaceut Sci Key Lab Adv;
Thiosemicarbazone; Lead optimization; Gastric cancer; Migration;
机译:基于硫代虫毒的铅优化,以发现高效率和低毒性的抗胃癌药剂
机译:从铅到药物候选者:3-(Phenylethyny1)-1H-吡唑并[3,4-d]嘧啶-4-胺衍生物作为三阴性乳腺癌治疗药物的优化
机译:作为新型潜在抗癌药的BAX直接激活剂的基于结构的先导优化和生物学评估
机译:FasL / B7-1基因修饰的肿瘤细胞诱导的抗胃癌主动免疫
机译:低毒药物抗癌疫苗治疗在HER2阳性乳腺癌治疗中的应用和增强
机译:基于需求的多目标方法用于广谱抗胃癌药物的虚拟筛选发现
机译:从导致药物候选物中:优化3(苯基乙炔基)1HPyrazolo 3,4d嘧啶-4-胺衍生物作为治疗三重阴性乳腺癌的药剂
机译:两种重金属的配位化学:I,配体对铅(II)络合的偏好,对铅中毒治疗剂的开发:II,钚溶解度和与环境相关的物种形成